←Back to list

Dossier

Affordable luxury-fragrance dupes sold direct-to-consumer
Dossier sells $29 fragrance 'impressions' inspired by $200-$300 designer scents, all formulated in Grasse, France and shipped direct-to-consumer. The company has built a sizable subscription base — over half of revenue is recurring — and reportedly crossed $100 million in annualized revenue in 2025. Dossier's hyper-clean unit economics on perfume have made it a frequently cited case study in the modern DTC playbook.
Consumer 📍 New York, NY Founded 2019
Current Valuation
Private
PRIVATE

IPO Outlookprivate

Is Dossier going public?
No. Dossier is private and has not filed to go public. There is no S-1 on file.
What is Dossier's valuation in 2026?
No confirmed valuation is on record for Dossier. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Dossier filed an S-1?
No public S-1 is on file for Dossier.
Who are Dossier's investors?
Dossier's investors include Clearco, Forerunner Ventures, Interplay.
Is Dossier publicly traded — can you buy Dossier stock?
No. Dossier is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Dossier on its Pre-IPO Access Desk.
How to actually get exposure to Dossier →
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

CEO
Sergio Tache
Founded
2019
HQ
New York, NY
Employees
~75
Est. Revenue
$100M (2025)
Growth
Roughly 2x year-over-year through 2024
IPO Status
private

Fundraising Status

Growth (debt + equity) · 3y 9mo ago
private

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Growth (debt + equity)—Jan 2023Clearco—

Talent Signal

Hiring trend
● First snapshot
trend accrues with monthly sweeps
Open roles
3
via careers page
Product-build share
67%
engineering, research, product, design
Trajectory
steady
heavy product build — 67% of open roles are product-building functions (engineering/research/product) — 1 of 3 open roles are marketing.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by month3Sep '26
Open roles by function
Open roles by functionMarketing1Design1Clinical & Science1
■ product-building   ■ go-to-market / G&A
Dossier Impressions Designer-inspired,CVS PharmacySkip to content
Counted from Dossier's live job board as of 2026-09-14; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.

Founders & Key People

Sergio Tache

Investors

Clearco · Forerunner Ventures · Interplay

Products

  • Designer fragrance impressions ($29)
  • Body care
  • Candles
  • Discovery sets
  • Subscription program

Competitors

Phlur · Snif · Oakcha · Maison Margiela Replica · Le Labo
DTCBeautyFragranceSubscription
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.